3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
91
NIH
32
INDUSTRY
15
NETWORK
10
UNKNOWN
1
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
11
Neoplasm Metastasis
6
Stomach Neoplasms
5
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction
2
Sarcoma
1
Recurrence
1
Lung Neoplasms
1
Gastrointestinal Neoplasms
1
Gastro-enteropancreatic neuroendocrine tumor
1
Colonic Neoplasms
1
Breast Neoplasms
1
Breast Cancer Metastatic
1
Interventions
Leucovorin
4
Fluorouracil
3
Oxaliplatin
2
Laparoscopy
2
Cetuximab
2
Capecitabine
2
tislelizumab
1
ferric maltol
1
envafolimab
1
Tranexamic Acid
1
Surgical Procedures, Operative
1
Ropivacaine
1
Propofol
1
Preoperative Exercise
1
Positron Emission Tomography Computed Tomography
1
Nivolumab
1
Nitrous Oxide
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Motivational Interviewing
1
Isoflurane
1
Irinotecan
1
Ipilimumab
1
Immunohistochemistry
1
HMPL-013
1
Folfox protocol
1
Filgrastim
1
Fentanyl
1
Epinephrine
1
Endoscopic Mucosal Resection
1
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Colonic Neoplasms
×
Irinotecan
×
Clear all
NCT00557102
2012-12-11
ERBIFORT
National Cancer Institute, France
Phase 2
Completed
24 enrolled